NO168177C - Analogifremgangsmaate for fremstilling av terapeutisk aktive polysykliske forbindelser - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive polysykliske forbindelser

Info

Publication number
NO168177C
NO168177C NO870564A NO870564A NO168177C NO 168177 C NO168177 C NO 168177C NO 870564 A NO870564 A NO 870564A NO 870564 A NO870564 A NO 870564A NO 168177 C NO168177 C NO 168177C
Authority
NO
Norway
Prior art keywords
policyclic
relations
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO870564A
Other languages
English (en)
Norwegian (no)
Other versions
NO168177B (no
NO870564D0 (no
NO870564L (no
Inventor
Ashit Kumar Ganguly
John Herbert Schwerdt
Richard James Friary
Marvin Ira Siegel
Sidney Randall Smith
Vera Ann Seidl
Edmund J Sybertz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO870564D0 publication Critical patent/NO870564D0/no
Publication of NO870564L publication Critical patent/NO870564L/no
Publication of NO168177B publication Critical patent/NO168177B/no
Publication of NO168177C publication Critical patent/NO168177C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/16Ring systems of three rings containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO870564A 1985-06-13 1987-02-12 Analogifremgangsmaate for fremstilling av terapeutisk aktive polysykliske forbindelser NO168177C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74486585A 1985-06-13 1985-06-13
US86178886A 1986-05-15 1986-05-15
PCT/US1986/001269 WO1986007359A2 (en) 1985-06-13 1986-06-13 Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives

Publications (4)

Publication Number Publication Date
NO870564D0 NO870564D0 (no) 1987-02-12
NO870564L NO870564L (no) 1987-02-12
NO168177B NO168177B (no) 1991-10-14
NO168177C true NO168177C (no) 1992-01-22

Family

ID=27114362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870564A NO168177C (no) 1985-06-13 1987-02-12 Analogifremgangsmaate for fremstilling av terapeutisk aktive polysykliske forbindelser

Country Status (19)

Country Link
EP (1) EP0229823B1 (da)
JP (1) JPH0762017B2 (da)
KR (1) KR900004831B1 (da)
AT (1) ATE67764T1 (da)
AU (1) AU591922B2 (da)
CA (1) CA1306255C (da)
DE (1) DE3681719D1 (da)
DK (1) DK70687A (da)
GR (1) GR861530B (da)
HK (1) HK94694A (da)
HU (1) HU203098B (da)
IE (1) IE60420B1 (da)
IL (1) IL79110A0 (da)
MY (1) MY101808A (da)
NO (1) NO168177C (da)
NZ (1) NZ216519A (da)
OA (1) OA08480A (da)
PT (1) PT82752B (da)
WO (1) WO1986007359A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3609795A1 (de) * 1986-03-22 1987-09-24 Goedecke Ag Pyrido(4,3-b)(1,6)naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung
US5366971A (en) * 1987-11-09 1994-11-22 Sandoz Ltd. Use of 11,28-dioxa-4-azatricyclo[22.3.1.04,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them
EP0952735B2 (en) * 1994-04-08 2007-12-26 United Video Properties, Inc. Interactive scroll program guide
CZ292631B6 (cs) * 1994-06-14 2003-11-12 Dainippon Pharmaceutical Co., Ltd. Deriváty pyridonkarboxylové kyseliny, protinádorové a farmakologické prostředky je obsahující
ATE277017T1 (de) * 1999-08-30 2004-10-15 Maruishi Pharma 1,2-disubstituierte 1,4-dihydro-4-oxochinolin- verbindungen
US9625475B2 (en) 2008-09-29 2017-04-18 Abbvie Inc. Indole and indoline derivatives and methods of use thereof
HU231285B1 (hu) 2018-04-18 2022-08-28 Printnet Kereskedelmi És Szolgáltató Kft. A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1585099A (da) * 1967-07-13 1970-01-09
DE2803541A1 (de) 1978-01-27 1979-08-02 Sandoz Ag Neue chinolinderivate, ihre herstellung und verwendung
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents

Also Published As

Publication number Publication date
NO168177B (no) 1991-10-14
EP0229823A1 (en) 1987-07-29
AU6122486A (en) 1987-01-07
KR900004831B1 (ko) 1990-07-07
IE861565L (en) 1986-12-13
EP0229823B1 (en) 1991-09-25
HU203098B (en) 1991-05-28
JPS63500518A (ja) 1988-02-25
KR870700622A (ko) 1987-12-30
NZ216519A (en) 1989-02-24
AU591922B2 (en) 1989-12-21
ATE67764T1 (de) 1991-10-15
HUT42482A (en) 1987-07-28
PT82752A (en) 1986-07-01
JPH0762017B2 (ja) 1995-07-05
WO1986007359A3 (en) 1987-04-09
DE3681719D1 (de) 1991-10-31
PT82752B (pt) 1988-12-15
NO870564D0 (no) 1987-02-12
IE60420B1 (en) 1994-07-13
OA08480A (en) 1988-07-29
WO1986007359A2 (en) 1986-12-18
CA1306255C (en) 1992-08-11
IL79110A0 (en) 1986-09-30
NO870564L (no) 1987-02-12
HK94694A (en) 1994-09-16
GR861530B (en) 1986-12-31
MY101808A (en) 1992-01-31
DK70687D0 (da) 1987-02-12
DK70687A (da) 1987-02-12

Similar Documents

Publication Publication Date Title
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO870397L (no) Fremgangsmaate for fremstilling av terapeutisk aktive organiske platinakomplekser.
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO168177C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polysykliske forbindelser
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO169169C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte benzimidazoler
NO873835D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner.
NO168103C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aralkylimidazolderivater
NO165923C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylsubstituerte nafthyridinderivater.
MY100071A (en) Aryl-substituted naphthyridine and pyridopyrazine derivatives
UA8421A1 (uk) Препарат для лікування опіків, трофічних язв та раневих пошкоджень шкіри віватон-2
NO170850C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-oxoprostaglandinderivater
NO170631C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-pyrimidinaminer
NO921475D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive catecholderivater
NO923052L (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive bezamidazolsulfonamidderivater